Navega Therapeutics
PrivateLast Round
Grant
Sep 25, 2025
Total Funding Raised
$8.93M
Momentum Score
50 /100
Company Overview
Navega Therapeutics is a biotechnology company developing non-permanent, epigenetic-regulation gene therapies to treat chronic pain and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, ML Platforms
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Application
Keywords
epigenetic gene therapychronic pain gene therapynon-addictive pain reliefopioid alternativeAI drug discoveryepigenetic editorsgene silencingNaV1.7 targetAAV gene therapyCRISPR therapyzinc finger proteinSCN9A gene repressiondCas9 systemneuropathic painsmall fiber neuropathy
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Navega Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Navega Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 25, 2025 | ||||
| Grant | Feb 4, 2025 | ||||
| Grant | Jan 27, 2022 | ||||
| Grant | Sep 29, 2021 | ||||
| Grant | Sep 26, 2019 | ||||
Grant | Sep 13, 2019 |
Navega Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
| NIH HEAL Initiative | Grant |
Navega Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Navega Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersSan Diego, California
Employee Range9
Year Founded2018
Last FundingSep 25, 2025